Hypertension frequently develops early after liver transplantation when cyclosporine-based immunosuppression is used. However, initial experience with tacrolimus has suggested that its use leads to a lower early incidence of hypertension. In this study, the blood pressure status of patients treated
Conversion from cyclosporin to FK 506 after liver transplantation
โ Scribed by M. Winkler; B. Ringe; U. Jost; M. Melter; B. Rodeck; T. Buhr; C. Brinkmann; R. Pichlmayr
- Publisher
- Springer
- Year
- 1993
- Tongue
- English
- Weight
- 664 KB
- Volume
- 6
- Category
- Article
- ISSN
- 0934-0874
No coin nor oath required. For personal study only.
๐ SIMILAR VOLUMES
The development of atherosclerotic cardiovascular complications is a common and serious problem for the long-term survivors of organ transplantation. Cyclosporine A plus steroid-based immuno-suppression regimens in these patients are associated with the development of hypertension, hyperlipidemia, o
We have reviewed our experience with conversion to tacrolimus after 435 liver transplantations. Tacrolimus was administered as a rescue agent in 33 patients until October 1993. Indications for rescue therapy were: cholestatic forms of severe, steroid-resistant cellular rejection (n = 8), OKT3-resist